PetzoldABalcerLJCalabresiPAet al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol2017; 16: 797–812.
2.
BrandtAUMartinez-LapiscinaEHNolanRet al. Monitoring the course of MS with optical coherence tomography. Curr Treat Options Neurol2017; 19: 15.
3.
SycSBWarnerCVHiremathGSet al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler2010; 16: 829–839.
4.
SaidhaSSycSBIbrahimMAet al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain2011; 134: 518–533.
5.
SchipplingSBalkLJCostelloFet al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler2015; 21: 163–170.
6.
SaidhaSSycSBDurbinMKet al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler2011; 17: 1449–1463.
7.
SaidhaSSotirchosESOhJet al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol2013; 70: 34–43.
8.
OhJSotirchosESSaidhaSet al. Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis. Neurology2015; 84: 720–728.
9.
RatchfordJNSaidhaSSotirchosESet al. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology2013; 80: 47–54.
10.
SaidhaSAl-LouziORatchfordJNet al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol2015; 78: 801–813.
11.
Martinez-LapiscinaEHArnowSWilsonJAet al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol2016; 15: 574–584.
12.
ButtonJAl-LouziOLangAet al. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study. Neurology2017; 88: 525–532.
13.
AzevedoCJPelletierD. Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis?Curr Opin Neurol2016; 29: 237–242.
14.
SaidhaSSotirchosESIbrahimMAet al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol2012; 11: 963–972.
15.
KnierBSchmidtPAlyLet al. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain2016; 139: 2855–2863.
